Talking about Alzheimer’s disease: current drugs, clinical trials, and the pipeline
Sometimes, there’s an interview that we do that’s just a bit long for the regular…
February 9, 2023 - 2 minutes
Sometimes, there’s an interview that we do that’s just a bit long for the regular…
BioArctic AB's partner Eisai says the European Medicines Agency (EMA) has accepted a marketing authorization…
Japanese companies Astellas Pharma Inc., Eisai Co., Ltd., Daiichi Sankyo Company, Limited, and Takeda Pharmaceutical…
A huge step forward in dementia research has been hailed a truly historic moment by…
Eisai Co., Ltd. and Biogen Inc. have announced positive topline results from Eisai’s large global…